November 08, 2024

NCCN Guidelines Have Expanded to Meet Growing Understanding of Hereditary Risk

The National Comprehensive Cancer Network (NCCN) introduced expanded NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) to account for the advanced understanding of hereditary cancer risk...

The ASCO Post

November 05, 2024

$2.5 Million Grant May Help Increase Lung Cancer Screenings in Underserved Communities

Researchers were awarded a $2.5 million grant from the Bristol Myers Squibb Foundation to establish a new initiative aimed at reducing disparities in lung cancer screening across Los Angeles County.

The ASCO Post

November 01, 2024

How End-of-Life Dreams and Visions Are Bringing Comfort to Dying Patients

Just weeks or even days or hours away from death, the majority of conscious terminally ill patients often experience growth and meaning in their lives and the absence of fear through end-of-life dream...

The ASCO Post

July 01, 2023

GA THERAPIES ON THE WAY

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Ophthalmology Management

January 12, 2024

Changing Medical Practice Through Translational Research Successes

Converting data and science into medical progress requires a strategic emphasis on work that matters to patients, either through imminent application to clinical practice or potentially transformative basic discoveries.

Cedars-Sinai Pulse

May 09, 2023

Fibula free flap (free tissue transfer) for mandibular reconstruction

Mayo Clinic otolaryngologist Eric J. Moore, M.D. demonstrates a fibular free flap reconstruction of a mandibular defect following an oncologic resection for oral cavity cancer.

Mayo Clinic

December 06, 2023

'Game-Changer’ Intervention for Ovarian Cancer Prevention

Gynecologic oncologist Rebecca Stone and colleagues at Johns Hopkins are leading the way in salpingectomy — a quick, low-risk surgical intervention that can significantly reduce the risk of ovarian cancer.

Johns Hopkins Medicine

March 29, 2023

TTUHSC El Paso Hunt School of Dental Medicine Receives $10,000 Gift from Trellis Company

TTUHSC El Paso Receives $10K from Trellis

Inside Dentistry

February 19, 2024

FDA Grants Accelerated Approval to Lifileucel for Unresectable or Metastatic Melanoma

On February 16, the FDA granted accelerated approval to lifileucel (Amtagvi), a tumor-derived autologous T-cell immunotherapy, for previously treated adult patients with unresectable or metastatic mel...

The ASCO Post